5,000 CBG plants (5,000 biogas plants target)

The target of 5,000 CBG plants is the Government of India's notional capacity ambition under the SATAT scheme — set when the scheme was launched on 1 October 2018 by the Ministry of Petroleum and Natural Gas. It translates roughly to 15 million tonnes per annum of bio-CNG production, requiring private investment of approximately ₹2 lakh crore and creating about 75,000 direct jobs.

The 5,000 number is built from a feedstock-availability bottom-up. India generates roughly 230 million tonnes per year of agricultural residues (paddy straw, wheat straw, sugarcane trash, cotton stalks), 60 million tonnes of organic municipal solid waste, 8 million tonnes of sugarcane press mud, and over a billion tonnes of livestock dung. Even at conservative recovery rates of 20-30% of these streams, the technically available biogas potential is enough to support 5,000-7,000 plants of 5-15 TPD CBG each. Spread across India's 700+ districts, the target works out to roughly 7 plants per district — geographically dispersed close to feedstock and demand.

The realised picture by 2024 is more sobering. About 4,000+ Letters of Intent have been issued, but only a few hundred plants are commissioned or in advanced construction, with another few hundred at varying stages of land acquisition, financing or DPR work. The conversion rate from LOI to commissioned plant is roughly 10-15% so far, with the gap reflecting feedstock-contract challenges, financial-closure delays, technology learning, and land/clearance bottlenecks rather than fundamental scheme weakness.

For developers the 5,000-plant target functions as a market-opportunity signal rather than a guaranteed pipeline. Each new plant entering operation eats into the local feedstock availability of others; CGD networks have finite injection capacity in each geographic area; OMC offtake schedules adjust to overall national supply. The disciplined posture is to treat the target as evidence of long-term sector commitment by the government while sizing one's own plant against actual local feedstock contracts, near-term OMC LOI capacity, and CGD injection availability — not against the national headline ambition.